Fonar Corporation

FONAR Corporation develops and markets MRI scanners for disease detection and diagnosis in the US. It operates two segments: Medical Equipment and Physician Management and Diagnostic Services. The company provides upright MRI scanners allowing patients to be scanned in various positions. Additionally, it offers non-medical management services, including administrative support. FONAR owns and operates diagnostic imaging facilities in Florida and manages MRI scanning facilities. Its scanners are marketed to private centers and hospital outpatient imaging facilities. Founded in 1970 and based in New York.

Overview

Sector

Healthcare

Target Price

34.7 USD

Current Price

15.1 USD

Potential

130%

Strengths

With an appreciation Potential of 129.31%, based on our fundamental analysis, it suggests the stock may be undervalued.
Current Price to Earnings Ratio (9.27) is lower than the sector mean (67.88).
Price to book ratio (0.59) is lower than the sector mean (9.96).
The company is well capitalized. The company has net cash and no outstanding debt.
EV/EBITDA (1.60) is lower than the sector mean (36.02).
EV/EBIT (2.16) is lower than the sector mean.
Price to free cash flow (7.38) is lower than the sector mean.
Strong EBITDA Margin of 25.37%.

Weaknesses

No significant weaknesses identified based on the analyzed metrics.

Key Financial Data

Indicator	Value
PER	9.2
EV/EBITDA	1.6
Price/Free Cash Flow'	7.3
ROIC	8.5%
Net Debt/EBITDA	-2.2